SynCore Biotechnology Co.,Ltd

NT$15.80As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4192Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (17.11%)
Div yield —
ROE (19.31%)
Biotechnology
Beta (5Y) 0.26
PE TTM —
TSR TTM (43.27%)
Mkt cap NT$555.6M
ROIC (12.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$18
16.27%
(31.01%)
Sell 3|7|10|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.23
0.24
0.25
0.27
24.72%
29.25%
27.09%
25.43%
RevenueNT$M
61.12
62.21
61.61
61.00
12.12%
11.27%
5.54%
2.11%
Peers (US$16.78M)
Cap (US$)
PE
18.87M
1,929x
18.21M
38.63x
Capital
TTM
5Y
10Y
Leveragex
2.924
(0.513)
(0.404)
EBIT/Intx
2.134
0.155
0.137
Own earn%
475.63
24.97
33.85
Sh yield%
38.16
45.08
44.40
Owners
Insiders/Inst%
6.56
76.18
Short interest%
1.65
SBC / revenue%
1.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
17–22
$1 testx
−0.2
Incr. ROIC%
2